CLINICAL_TRIALS
trial_result
· 2021-01-08
Clinical Trial Update: Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty [Phase 3]
Summary
Phase 3 trial results for the XaraColl bupivacaine implant after hernioplasty have been completed, reporting efficacy and safety data.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Innocoll | Conditions: Pain, Postoperative | Phase 3 | Status: COMPLETED | Results posted: 2021-01-08